Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Breast Neoplasms 25Neoplasms 12Stomach Neoplasms 10Endometrial Neoplasms 10Lung Neoplasms 9Lymphatic Metastasis 7Melanoma 6Head and Neck Neoplasms 6Carcinoma, Hepatocellular 6Uterine Cervical Neoplasms 5Rectal Neoplasms 5Esophageal Neoplasms 5Colonic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Vulvar Neoplasms 3Sarcoma 3Prostatic Neoplasms 3Ovarian Neoplasms 3Colorectal Neoplasms 3Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Skull Base Neoplasms 2Sarcoma, Ewing 2Rhabdomyosarcoma 2Peritoneal Neoplasms 2Osteosarcoma 2Margins of Excision 2Lymphedema 2Hypoparathyroidism 2Giant Cell Tumor of Bone 2

Interventions

Cyclophosphamide 297Rituximab 272Etoposide 149Filgrastim 142fludarabine phosphate 120Cytarabine 109Vincristine 107Melphalan 102Radiotherapy 101Doxorubicin 97Peripheral Blood Stem Cell Transplantation 93Methotrexate 91fludarabine 86Prednisone 86Busulfan 86Tacrolimus 66Mycophenolic Acid 62Granulocyte Colony-Stimulating Factor 60Antilymphocyte Serum 58Dexamethasone 57Whole-Body Irradiation 55Carmustine 54Bortezomib 45Cyclosporine 44Lenalidomide 41Methylprednisolone 40sargramostim 39Bendamustine Hydrochloride 37ibritumomab tiuxetan 34Ifosfamide 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Lymphoma × Indocyanine Green × Clear all
NCT04084067 2026-04-30

Indocyanine Green (ICG) Guided Tumor Resection

St. Jude Children's Research Hospital

Phase 1 Recruiting
230 enrolled
CNSGastrointestinalGenitourinaryLymphoidSarcoma

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lymphoma, Neoplasms, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡